Moderna says Phase 2/3 study of CoVID vaccine in kids aged 6 to 11 showed ‘robust’ antibody response after 2 50 mg doses

1 BUSINESS

Business News - Opportunities - Reviews

 

 

Moderna Inc.

Moderna, Inc. engages in the development of transformative medicines based on messenger ribonucleic acid (mRNA). Its product pipeline includes the following modalities: prophylactic vaccines, cancer vaccines, intratumoral immuno-oncology, localized regenerative therapeutics, systemic secreted therapeutics, and systemic intracellular therapeutics. The company was founded by Noubar B. Afeyan, Robert S. Langer, Jr., Derrick J. Rose and Kenneth R. Chien in 2010 and is headquartered in Cambridge, MA.

1 BUSINESS

Business News - Opportunities - Reviews

 

 

Leave a Reply